What is Generate Biomedicines, Inc. 's EBIT?

Generate Biomedicines, Inc. (GENB) reported EBIT of -$64.11M in Q1 2026.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Generate Biomedicines, Inc. GENB EBIT

EBIT at other companies

MYR GroupMYRG

$64.72M+88.7%

RepligenRGEN

$15.94M+142%

SSR MiningSSRM

$300.38M+181%

NNN REITNNN

$146.65M+1.9%

LKQLKQ

$217M-18.7%

CHE

ChemedCHE

$84.58M-10.7%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

−$64.1Moperating income−$61.7Mincome before tax+$182.0Kinterest expense=-$64.11M

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's EBIT?: Generate Biomedicines, Inc. (GENB) reported EBIT of -$64.11M in Q1 2026.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.